Benzinga · Apr 7, 2026
NASDAQ · SWKHL
SWK Holdings Corporation 9.00% Senior Notes due 2027
Financial Services · Asset Management
$25.14
Down-$0.43 (-1.68%)
Updated Sep 16, 2026, 11:31 AM
SID Score
4.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 180.59M
- P/E ratio
- 12.18
- Dividend yield
- 8.96%
- 52-week range
- $24.34 – $25.79
- Volume
- 8.57K
- Avg. volume
- 2.82K
Price performance
SWKHL price history
1M range · 19 trading sessions · Daily adjusted prices
SWKHL closed at $25.14 after 19 trading sessions, down 1.06% for the selected period.
- Last close
- $25.14
- Period change
- -1.06%
- Period low
- $25.14
- Period high
- $25.59
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $25.02 | $25.14 | $25.02 | $25.14 | 8.57K |
| Sep 14, 2026 | $25.51 | $25.57 | $25.51 | $25.57 | 3.66K |
| Sep 11, 2026 | $25.54 | $25.59 | $25.49 | $25.5899 | 1.98K |
| Sep 10, 2026 | $25.54 | $25.54 | $25.47 | $25.505 | 7.26K |
| Sep 9, 2026 | $25.50 | $25.54 | $25.50 | $25.5399 | 4.08K |
| Sep 8, 2026 | $25.49 | $25.51 | $25.47 | $25.49 | 6.86K |
| Sep 4, 2026 | $25.48 | $25.56 | $25.48 | $25.56 | 3.22K |
| Sep 2, 2026 | $25.48 | $25.48 | $25.45 | $25.4599 | 1.53K |
| Sep 1, 2026 | $25.47 | $25.48 | $25.47 | $25.48 | 229 |
| Aug 31, 2026 | $25.48 | $25.48 | $25.44 | $25.4401 | 636 |
| Aug 28, 2026 | $25.45 | $25.48 | $25.41 | $25.4204 | 2.34K |
| Aug 27, 2026 | $25.45 | $25.45 | $25.42 | $25.4201 | 1.56K |
| Aug 26, 2026 | $25.45 | $25.45 | $25.44 | $25.44 | 1.49K |
| Aug 25, 2026 | $25.43 | $25.45 | $25.43 | $25.4499 | 626 |
| Aug 24, 2026 | $25.44 | $25.44 | $25.415 | $25.43 | 618 |
| Aug 21, 2026 | $25.45 | $25.45 | $25.425 | $25.425 | 293 |
| Aug 20, 2026 | $25.45 | $25.45 | $25.45 | $25.45 | 1.38K |
| Aug 19, 2026 | $25.44 | $25.44 | $25.44 | $25.44 | 1.02K |
| Aug 18, 2026 | $25.46 | $25.46 | $25.41 | $25.41 | 2.15K |
Latest SWKHL news
The latest Smart Investors Daily articles mentioning SWKHL.
Stock researchCompany · Overview
SWKHL research
Overview
Company profile and research snapshot.
Company profile
SWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector. It operates in two segments, Finance Receivables and Pharmaceutical Development. The company provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. It also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. In addition, the company engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform. Further, it intends to out-license its internal product pipeline to create novel formulations using its proprietary technology to develop treatments for patients and caregivers. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was founded in 1996 and is headquartered in Dallas, Texas.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
SeekingAlpha · Dec 31, 2025
SWKHL: Attractive Baby Bond After The Merger, 9% Coupon
Runway Growth Finance is set to acquire SWK Holdings in Q1 2026. Read why I rate SWKHL stock a Buy.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.

